The US Food and Drug Administration on Thursday revised the emergency use authorization for Evusheld, a monoclonal antibody against Covid-19 for immunocompromised people and those who cannot be vaccinated for medical reasons, to double the initial dose.
from Google Alert - health https://ift.tt/iAQLHlG
via IFTTT
0 comments:
Post a Comment